FDA Approved: MEKTOVI — Supplemental Application (Array BioPharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for MEKTOVI (binimetinib) submitted by Array BioPharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MEKTOVI (BINIMETINIB)

Snippet

SUPPL AP for MEKTOVI (BINIMETINIB)